Literature DB >> 12540627

Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes.

Patrizio Odetti1, Carlo Pesce, Nicola Traverso, Stefano Menini, Elena Pesce Maineri, Luana Cosso, Sabina Valentini, Stefania Patriarca, Damiano Cottalasso, Umberto M Marinari, Maria Adelaide Pronzato.   

Abstract

This study analyzes the effect of chronic treatment with different antioxidants (N-acetyl-cysteine [NAC], taurine, a combination of NAC and taurine, and oxerutin) on long-term experimental diabetes induced by streptozotocin in rats. Glycoxidative damage was evaluated in the skin; glomerular structural changes were studied with morphometry and immunohistochemistry. Oxerutin treatment and the combined NAC plus taurine treatment resulted in reduced accumulation of collagen-linked fluorescence in skin in comparison with untreated diabetic rats. All treatments except taurine reduced glomerular accumulation of N(epsilon)-(carboxymethyl)lysine and protected against the increase in glomerular volume typical of diabetes; furthermore, the apoptosis rate was significantly decreased and the glomerular cell density was better preserved. Glycoxidative markers in the skin turned out to be good indicators of the glomerular condition. The findings that emerged from our study support the hypothesis that glomerular damage in diabetes can be prevented or at least attenuated by supplementation with specific antioxidants. Treatment with oxerutin and combined treatment with NAC plus taurine gave the most encouraging results, whereas the results of taurine-only treatment were either negligible or negative and therefore suggest caution in the use of this molecule in single-drug treatment courses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12540627     DOI: 10.2337/diabetes.52.2.499

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

1.  Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats.

Authors:  Yuan Zhu; Xiao-Ling Zhang; Bo-Feng Zhu; Yan-Ning Ding
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

Review 2.  N-acetylcysteine -- passe-partout or much ado about nothing?

Authors:  Mirja-Liisa Aitio
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

3.  Arsenic exposure intensifies glycogen nephrosis in diabetic rats.

Authors:  Marcela Nascimento Sertorio; Ana Cláudia Ferreira Souza; Daniel Silva Sena Bastos; Felipe Couto Santos; Luiz Otávio Guimarães Ervilha; Kenner Morais Fernandes; Leandro Licursi de Oliveira; Mariana Machado-Neves
Journal:  Environ Sci Pollut Res Int       Date:  2019-03-07       Impact factor: 4.223

4.  Dietary taurine supplementation prevents glial alterations in retina of diabetic rats.

Authors:  Kaihong Zeng; Hongxia Xu; Mantian Mi; Qianyong Zhang; Yajie Zhang; Ka Chen; Fang Chen; Jundong Zhu; Xiaoping Yu
Journal:  Neurochem Res       Date:  2008-06-18       Impact factor: 3.996

5.  Effect of taurine and acetylcysteine in attenuating microalbuminuria in type 2 diabetes.

Authors:  V Viswanathan; M B Nair; P Tilak
Journal:  Indian J Nephrol       Date:  2008-04

Review 6.  Is taurine beneficial in reducing risk factors for diabetes mellitus?

Authors:  Flavia Franconi; Mauro A S Di Leo; Federico Bennardini; Giovanni Ghirlanda
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

7.  Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease.

Authors:  S Menini; C Iacobini; G Oddi; C Ricci; P Simonelli; S Fallucca; M Grattarola; F Pugliese; C Pesce; G Pugliese
Journal:  Diabetologia       Date:  2007-09-28       Impact factor: 10.122

Review 8.  Glutathione dysregulation and the etiology and progression of human diseases.

Authors:  Nazzareno Ballatori; Suzanne M Krance; Sylvia Notenboom; Shujie Shi; Kim Tieu; Christine L Hammond
Journal:  Biol Chem       Date:  2009-03       Impact factor: 3.915

9.  N-acetyl cysteine in clomiphene citrate resistant polycystic ovary syndrome: A review of reported outcomes.

Authors:  Lekha Saha; Sharonjeet Kaur; Pradip Kumar Saha
Journal:  J Pharmacol Pharmacother       Date:  2013-07

10.  An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes.

Authors:  Alessandra Puddu; François Mach; Alessio Nencioni; Giorgio Luciano Viviani; Fabrizio Montecucco
Journal:  Mediators Inflamm       Date:  2013-01-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.